Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type

Antiviral Research

Volumn 29, Issue 2-3, 1996, Pages 297-307

  Esté, José A ^a   De Vreese, Karen ^a   Witvrouw, Myriam ^a   Schmit, Jean Claude ^a   Vandamme, Anne Mieke ^a   Anné, Jozef ^a   Desmyter, Jan ^a   Henson, Geoffrey W ^b   Bridger, Gary ^b   De Clercq, Erik ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b Johnson Matthey Pharmaceutical Res   (United States)

Author keywords

Anti HIV agents: Bicyclams; Resistance: JM3100

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); 1,1' PROPYLENEBIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); ALPHA ANILINOPHENYLACETAMIDE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; AURINTRICARBOXYLIC ACID; BETA CYCLODEXTRIN TETRADECASULFATE; BICYCLAM DERIVATIVE; DEXTRAN SULFATE; DIDANOSINE; GAMMA CYCLODEXTRIN DERIVATIVE; HEPARIN; JM 2763; LAMIVUDINE; LOVIRIDE; PENTOSAN SULFATE; POLYVINYL ALCOHOL SULFATE; R 97362; RNA DIRECTED DNA POLYMERASE INHIBITOR; TIBO DERIVATIVE; TIVIRAPINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SYNCYTIUM; T LYMPHOCYTE;

ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; HETEROCYCLIC COMPOUNDS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; POLYMERS; REVERSE TRANSCRIPTASE INHIBITORS; TUMOR CELLS, CULTURED;

EID: 0029916728     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00936-1     Document Type: Article

References (28)

1. Adachi, A., Gendelman, H., Koenig, S., Folks, T., Willey, R., Rabson, A. and Martin, M. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291.
2. Baba, M., Pauwels, R., Balzarini, J., Herdewijn, P., De Clercq, E. and Desmyter, J. (1987) Rivabirin antagonizes inhibitory effects of pyrimidine 2′,3′-dideoxynucleosides but enhances inhibitory effects of purine 2′,3′-dideoxynucleosides on replication of human immunodeficiency virus in vitro. Antimicrob. Agents Chemother. 31, 1613-1617.
3. Balzarini, J., Karlsson, A., Pérez-Pérez, M., Camarasa, M., Tarpley, W. and De Clercq, E. (1993) Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus. Virology 196, 576-585.
4. Bridger, G., Skerlj, R., Thornton, D., et al. (1995) Synthesis and structure-activity relationship of phenylenebis(-methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker. J. Med. Chem. 38, 366-378.
5. De Clercq, E. (1992) Human immunodeficiency virus inhibitors targeted at virus-cell fusion and/or viral uncoating. Int. J. lmmunother. 8, 115-123.
6. De Clercq, E., Yamamoto, N., Pauwels, R., et al. (1992) Potent and selective inhibition of human immunodeficiency virus (HIV-1 and HIV-2) replication by a class of bicyclams interacting with a viral uncoating event. Proc. Natl. Acad. Sci. U.S.A. 89, 5286-5290.
7. De Clercq, E., Yamamoto N., Pauwels, R., et al. (1994) Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM 3100. Antimicrob. Agents Chemother. 38, 668-674.
8. De Vreese, K., Kofler-Mongold, V., Leutgeb, C., et al. (1996a) The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. J. Virol., 70, 689-696.
9. De Vreese, K., Reymen, D., Griffin, P., et al. (1996b) The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding. Antiviral Res., in press.
10. Domingo, E. and Holland, J. (1994) Mutation rates and rapid evolution of RNA viruses. In: S.S. Morse (Ed), Evolutionary Biology of Viruses, pp. 161 184. Raven Press, New York.
11. Ghiara, J., Stura, E., Satanfield, R., Profy, A. and Wilson, I. (1994) Crystal structure of the principal neutralization site of HIV-1. Science 264, 82-85.
12. Goldthorpe, S., Kinchington, D. and Lovelidge, D. (1995) Current antiviral agents. Int. Antiviral News 3, 92-98.
13. Gu, Z., Gao, Q., Li, X., Parniak, M. and Wainberg, M. (1992) Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2′,3′-dideoxycytidine. J. Virol. 66, 7128-7135.
14. Harada, S., Koyanagi, Y. and Yamamoto, N. (1985) Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4: an application in a plaque assay. Science 229, 563-566.
15. Javaherian, K., Khiroya, R., Quinlan, C., Boyd, J. and Hanham, K. (1995) V3-mediated heparin neutralization of HIV type 1. AIDS Res. Hum. Retroviruses 10, 1421-1423.
16. Larder, B., Kellam, P. and Kemp, S. (1991) Zidovudine resistance predicted by direct detection of mutations in DNA from human immunodeficiency virus infected lymphocytes. AIDS 5, 137-144.
17. Najera, L. Holguin, A., Quiñones-Mateu, M., et al. (1995) pol Gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69, 23-31.
18. Pauwels, R., Balzarini, J., Baba, M., et al. (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20, 309-321.
19. Pauwels, R., Andries, K., Desmyter, J., et al. (1990) Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343, 470-474.
20. Pauwels, R., Andries, K., Debyser, Z., et al. (1993) Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of α-amlinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 90, 1711-1715.
21. Prichard, M., Prichard, L., Baguley, W., Nassiri, M. and Shipman, C. (1990) Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine. Antimicrob. Agents Chemother. 35, 1060-1065.
22. Schols, D., De Clercq, E., Witvrouw, M., et al. (1991) Sulphated cyclodextrins are potent anti-HIV agents acting synergistically with 2′,3′-dideoxynucleoside analogues. Antiviral Chem. Chemother. 2, 45-53.
23. St.Clair, M., Martin, J. and Tudor-Williams, G. (1991) Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253, 1557-1559.
24. Tisdale, M., Kemp, S., Parry, N. and Larder, B. (1993) Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 90, 5653-5656.
25. Vandamme, A.-M., Debyser, Z., Pauwels, R., et al. (1994) Characterization of HIV-1 strains isolated from patients treated with TIBO R82913. AIDS Res. Hum. Retrovir. 10, 39-46.
26. Witvrouw, M., Esté, J.A., Quiñones-Mateu, M., et al. (1994a) Activity of a sulfated polysaccharide extracted from the red seaweed Aghardiella tenera against human immunodeficiency virus and other enveloped viruses. Antiviral Chem. Chemother. 5, 297-303.
27. Witvrouw, M., Desmyter, J. and De Clercq, E. (1994b) Antiviral portrait series: 4. Polysulfates as inhibitors of HIV and other enveloped viruses. Antiviral Chem. Chemother. 5, 345-359.
28. Witvrouw, M., Sifert, J.M., Henson, G., Martellucci, S.A., Desmyter, J. and De Clercq, E. (1996) Pharmacokinetics of the anti-HIV bicyclam SID791 (JM3100) in rabbits, as determined by both analytical and bioassay methods. Antiviral Chem. Chemother., 7, 27-30.